Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Symic selects SB-061 as first osteoarthritis clinical candidate

Nov. 19, 2015

Preclinical and clinical results of SM-04690 for the treatment of osteoarthritis

Nov. 19, 2015

Phase I results for FPA-008 in RA

Nov. 18, 2015

First-in-patient data for anti-fractalkine MAb E-6011 in RA

Nov. 18, 2015

Long-term data for olokizumab in rheumatoid arthritis

Nov. 18, 2015

Phase I data for biosimilar adalimumab, BI-695501

Nov. 17, 2015

AstraZeneca starts phase I study of MEDI-7352 in patients with osteoarthritis

Nov. 17, 2015

NIP-565: a JAK-1 inhibitor for rheumatoid arthritis

Nov. 16, 2015

Horizon Pharma partners with ALR to study Rayos delayed-release tablets for SLE

Nov. 13, 2015

GKT-137831 receives orphan drug designation in the E.U. for systemic sclerosis

Nov. 11, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...